Login / Signup

Microsomal prostaglandin E synthase-1 inhibition prevents adverse cardiac remodelling after myocardial infarction in mice.

Yuze ZhangJulia Steinmetz-SpähHelena IdborgLiyuan ZhuHuihui LiHaojie RaoZengrong ChenZiyi GuoLejia HuChuansheng XuHong ChenMarina KorotkovaPer-Johan JakobssonMiao Wang
Published in: British journal of pharmacology (2023)
metabolite ratio and therefore represents a potential therapeutic strategy for development of HFrEF after MI.
Keyphrases
  • high fat diet induced
  • left ventricular
  • mouse model
  • type diabetes
  • emergency department
  • insulin resistance
  • adverse drug
  • electronic health record